Use of Magnetic Resonance Imaging to Guide Preoperative Accelerated Partial Breast Irradiation in the Prone Position and Treatment Response in Clinical Stage 1 Hormone Sensitive Breast Cancer: A Phase 1/2 Study
Abstract
Purpose: The challenges of postoperative accelerated partial breast irradiation (APBI) include targeting inaccuracies and inability to measure tumor response. We hypothesized that the tumor could be targeted with preoperative APBI (pAPBI) using magnetic resonance imaging (MRI) in prone position with our established prone breast technique. This feasibility study aimed to assess the accuracy and tumor response of pAPBI using our MRI/computed tomography (CT)-guided prone technology.
Methods and materials: This prospective study enrolled patients aged >50 years with clinical stage IA ER+ breast cancer intending lumpectomy. Axillary ultrasound and MRI confirmed clinically negative nodes. Planning CT, MRI, and pAPBI (3850 cGy in 10 fractions twice a day) used the same prone immobilization platform. Another MRI was obtained 4 weeks after APBI to quantitatively measure tumor response. Lumpectomy was performed 4 to 6 weeks after pAPBI. Simon's 2-stage design required assessment after accrual of the first 19 patients for feasibility.
Results: Nineteen patients with clinical stage IA ER+/PR+/HER2- breast cancer with median age of 65 years (range, 51-78 years) completed pAPBI followed by lumpectomy and endocrine therapy. Median follow-up was 73.8 months (IQR, 58.6-82.5 months). Median clinical tumor size was 0.9 cm (IQR, 0.8-1.6 cm). There was complete pathologic response in 10.5% (2) patients and another 36.8% (7) were downstaged after pAPBI. MRI-detected tumor response significantly…
How strong is the evidence?
Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 19 participants or records.
Read the paper
Related studies
- Preliminary Toxicity Analysis of 3DCRT versus IMRT on the High Dose Arm of the RTOG 0126 Prostate Cancer Trial
- Adaptive Radiotherapy for Head and Neck Cancer: Initial Clinical Outcomes from a Prospective Trial
- American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology
- Motion Management Strategies and Technical Issues Associated with Stereotactic Body Radiotherapy of Thoracic and Upper Abdominal Tumors: A Review from NRG Oncology
- High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial
- Highly efficient training, refinement, and validation of a knowledge-based plan quality control system for radiotherapy clinical trials
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.